Case File №
#VI-2026-0217
Peptide Worldwide
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
29 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| Retatrutide | X Unrated | 1 | 7.1 | 7.1 | 7.1 | 6 May 2025 |
| ACE-031 | X N/A | 1 | 4.5 | 4.5 | 4.5 | 16 Mar 2025 |
| Andarine S4 | X N/A | 1 | 7.6 | 7.6 | 7.6 | 2 Apr 2025 |
| BAC Water | X N/A | 1 | 6.8 | 6.8 | 6.8 | 24 Apr 2025 |
| Botulinum toxin | X N/A | 1 | 6.7 | 6.7 | 6.7 | 13 Feb 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 7.5 | 7.5 | 7.5 | 24 Apr 2025 |
| Bronchogen | X N/A | 1 | 5.6 | 5.6 | 5.6 | 13 Feb 2025 |
| Cagrilintide 5mg + Semaglutide 5mg Blend | X N/A | 1 | 7.5 | 7.5 | 7.5 | 2 Jul 2025 |
| Cardiogen | X N/A | 1 | 7.4 | 7.4 | 7.4 | 17 Dec 2024 |
| Cerebrolysin | X N/A | 1 | 8.2 | 8.2 | 8.2 | 2 Jul 2025 |
| GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | X N/A | 1 | 6.5 | 6.5 | 6.5 | 13 Feb 2025 |
| IGF-1 LR3 | X N/A | 1 | 6.1 | 6.1 | 6.1 | 3 Jul 2025 |
| KissPeptin-10 | X N/A | 1 | 5.8 | 5.8 | 5.8 | 16 Mar 2025 |
| KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | X N/A | 1 | 6.0 | 6.0 | 6.0 | 9 Jun 2025 |
| MT-1 | X N/A | 1 | 5.6 | 5.6 | 5.6 | 2 Apr 2025 |
| N-Acetyl Epitalon Amidate | X N/A | 1 | 5.9 | 5.9 | 5.9 | 24 Apr 2025 |
| NA Selank Amidate | X N/A | 1 | 7.3 | 7.3 | 7.3 | 20 Jun 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 8.2 | 8.2 | 8.2 | 9 Jun 2025 |
| Oxytocin Acetate | X N/A | 1 | 6.2 | 6.2 | 6.2 | 17 Dec 2024 |
| P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 | X N/A | 1 | 7.3 | 7.3 | 7.3 | 2 Apr 2025 |
| Phenylacetic acid CAS 103-82-2 | X N/A | 1 | 5.9 | 5.9 | 5.9 | 14 Jan 2025 |
| PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | X N/A | 1 | 6.9 | 6.9 | 6.9 | 3 Jul 2025 |
| Primobolan Oral (Methenolone Acetate) | X N/A | 1 | 7.5 | 7.5 | 7.5 | 28 Mar 2025 |
| PTD-DBM | X N/A | 1 | 7.5 | 7.5 | 7.5 | 16 Mar 2025 |
| Salbutamol | X N/A | 1 | 7.7 | 7.7 | 7.7 | 3 Jul 2025 |
| Tesamorelin 11mg + Ipamorelin 6mg Blend | X N/A | 1 | 6.5 | 6.5 | 6.5 | 17 Dec 2024 |
| Test Cypionate | X N/A | 1 | 8.6 | 8.6 | 8.6 | 25 Apr 2025 |
| Thymosin Alpha-1 | X N/A | 1 | 9.4 | 9.4 | 9.4 | 16 Mar 2025 |
| Tren Base | X N/A | 1 | 4.8 | 4.8 | 4.8 | 2 Jul 2025 |
Exhibit II
Evidence Log
29 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 24 May 2026 | Cardiogen | 5.8 B | 50mg | 54.0mg | +8.0% | 99.62% | egtgpz | Lab E | Public |
| 24 May 2026 | GLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg | 6.7 A | 5mg | 5.2mg | +4.9% | 95.82% | nucqew | Lab G | Community |
| 24 May 2026 | MT-1 | 4.0 C | 50mg | 51.2mg | +2.5% | 95.07% | nvuroe | Lab E | Public |
| 24 May 2026 | Oxytocin Acetate | 4.7 C | 50mg | 61.0mg | +22.0% | 99.81% | olqi88 | Lab D | Community |
| 24 May 2026 | Salbutamol | 7.6 A | 25mg | 22.0mg | -11.9% | 96.28% | 695wmk | Lab C | Public |
| 24 May 2026 | Tesamorelin 11mg + Ipamorelin 6mg Blend | 5.2 B | 50mg | 54.3mg | +8.7% | 99.56% | hq1w1n | Lab C | Community |
| 23 May 2026 | KLOW GHK-CU 50mg+TB500 10mg+BPC157 10mg+KPV 10mg | 6.6 A | 30mg | 27.1mg | -9.8% | 98.05% | utdtbz | Lab B | Public |
| 21 May 2026 | Cerebrolysin | 8.4 A | 15mg | 14.1mg | -6.1% | 95.95% | wy6pku | Lab A | Community |
| 21 May 2026 | Test Cypionate | 9.4 A | 200mg/ml | 170.9mg/ml | -14.5% | 95.18% | g1m1kr | Lab D | Public |
| 20 May 2026 | Thymosin Alpha-1 | 10.0 A | 15mg | 18.3mg | +21.9% | 97.53% | tsske9 | Lab E | Public |
| 19 May 2026 | Phenylacetic acid CAS 103-82-2 | 5.8 B | 10g | 11.2g | +12.4% | 98.13% | ay9ulx | Lab C | Community |
| 29 Jan 2026 | Bronchogen | 4.7 C | 10mg | 10.6mg | +5.9% | 99.91% | sm2l9u | Lab B | Public |
| 29 Jan 2026 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 8.1 A | 2mg | 1.9mg | -5.2% | 95.36% | v9qo5c | Lab B | Public |
| 29 Jan 2026 | PTD-DBM | 8.5 A | 20mg | 23.8mg | +19.1% | 96.77% | 8tgn8a | Lab A | Public |
| 19 Jan 2026 | Botulinum toxin | 5.1 B | 2mg | 2.0mg | -1.5% | 97.85% | 8qtjiw | Lab E | Public |
| 19 Jan 2026 | PMK glycidic acid (3,4-MDP-2-P methyl glycidic acid / sodium salt) CAS 1369021-80-6 | 8.5 A | 1g | 1.1g | +6.8% | 97.62% | is53qc | Lab E | Public |
| 9 Jan 2026 | P-2-P (phenyl-2-propanone / BMK) CAS 103-79-7 | 7.1 A | 1g | 1.1g | +13.7% | 97.77% | 0aeahv | Lab E | Community |
| 7 Jan 2026 | Andarine S4 | 8.3 A | 100mg | 85.5mg | -14.5% | 96.41% | bx5erb | Lab B | Public |
| 6 Jan 2026 | Cagrilintide 5mg + Semaglutide 5mg Blend | 7.0 A | 30mg | 36.5mg | +21.6% | 96.25% | ivfq01 | Lab C | Public |
| 12 Dec 2025 | BAC Water | 5.2 B | 2mg | 2.0mg | +2.5% | 98.53% | xc0isk | Lab C | Community |
| 12 Dec 2025 | Primobolan Oral (Methenolone Acetate) | 7.1 A | 10mg | 9.2mg | -8.0% | 95.14% | z51qr8 | Lab D | Community |
| 5 Dec 2025 | ACE-031 | 5.5 B | 2mg | 1.8mg | -8.2% | 97.40% | 9o6q4w | Lab E | Public |
| 14 Nov 2025 | BPC157 5mg + TB500 5mg Blend | 8.9 A | 2mg | 2.0mg | +1.6% | 99.27% | 194r90 | Lab E | Public |
| 14 Nov 2025 | Tren Base | 6.7 A | 250mg/ml | 288.3mg/ml | +15.3% | 95.33% | gzdsw7 | Lab E | Community |
| 5 Nov 2025 | IGF-1 LR3 | 6.6 A | 2mg | 2.3mg | +14.8% | 98.26% | yxcmwq | Lab D | Community |
| 4 Nov 2025 | KissPeptin-10 | 5.8 B | 20mg | 17.5mg | -12.4% | 97.39% | 4abrxx | Lab G | Community |
| 17 Oct 2025 | NA Selank Amidate | 6.2 A | 15mg | 16.0mg | +7.0% | 96.92% | si5d3q | Lab G | Public |
| 9 Oct 2025 | N-Acetyl Epitalon Amidate | 6.7 A | 2mg | 2.2mg | +9.8% | 95.73% | g8y5dw | Lab G | Public |
| 6 May 2025 | Retatrutide | 7.1 A | 10mg | 10.28mg | +2.8% | 99.52% | (no batch ID) | Lab C | Public |
— END OF EVIDENCE LOG —